SNORD63 and nonpapillary renal cell carcinoma: Importantly, SNORD63 in US and SNORD96A in plasma possessed the favorable diagnostic efficiency, suggesting that aberrant expression of SNORD63 and SNORD96A act as diagnostic promising biomarkers for ccRCC.